Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Odefsey

- PMLiVE

Gilead advances HIV drug into phase III

The treatment is a chemical variant of Gilead's successful HIV drug Viread

- PMLiVE

GSK, Pfizer and Shionogi rewrite HIV joint venture terms

Comes ahead of first regulatory submissions for lead drug candidate dolutegravir

- PMLiVE

Tonio Borg nominated to replace John Dalli as EC Health Commissioner

Candidacy of the Maltese deputy prime minister and minister of foreign affairs accepted by Barroso

- PMLiVE

EC releases draft designs for legal online pharmacy logo

Says an official logo will help consumers verify authenticity of internet pharmacies

- PMLiVE

EC health commissioner John Dalli resigns after anti-fraud case

Linked to attempt to influence tobacco policy

- PMLiVE

Indonesia breaks seven HIV, hepatitis drug patents

Merck & Co, GSK, Gilead, Abbott and BMS all effected

Shionogi-ViiV to file HIV drug dolutegravir for approval

GSK, Pfizer and Shionogi joint venture completes phase III trials programme

- PMLiVE

German doctors criticise EU clinical trial reform plans

Could compromise patient safety says German Medical Association

European Commission launches iCoach app to help smokers quit

The mobile anti-smoking campaign is part of the EC's on-going Ex-smokers are Unstoppable push

- PMLiVE

European Commission takes quit smoking campaign mobile

New iCoach Android and iPhone app is part of the EC's on-going Ex-smokers are Unstoppable push

PAN celebrates 20 years by getting creative for charity

Creative agency PAN celebrated 20 years in healthcare communications with a day out at HIV charity Body & Soul’s centre in North London

- PMLiVE

Europe developing roadmap for mHealth use and acceptance

EU's MovingLife project is currently consulting on mHealth needs and requirements

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links